Feb 14, 2022 / 06:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to the Acasti Pharma Third Quarter Fiscal 2022 Business Update Conference Call. (Operator Instructions)
It is now my pleasure to turn the floor over to your host, David Waldman with Investor Relations. Sir, the floor is yours.
David K. Waldman - Crescendo Communications, LLC - President & CEO
Thank you, Holly, and good afternoon, everyone. I'd like to welcome you to Acasti Pharma's fiscal 2022 third quarter conference call. On the call with us this afternoon are Jan D'Alvise, President and CEO; Brian Ford, Chief Financial Officer; Dr. Pierre Lemieux, Chief Operating Officer, Canada, and Chief Scientific Officer; Dr. George Kottayil, Chief Operating Officer, U.S.; and Prashant Kohli, Vice President of Commercial Operations.
Following our prepared remarks, there will be a Q&A session. Should any questions remain after the call, please contact Crescendo Communications at (212) 671-1020. I'd also like to remind everyone that statements on this conference call that are not statements of historical
Q3 2022 Acasti Pharma Inc Earnings Call Transcript
Feb 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers